Octreotide prevents the pathological alterations of bowel obstruction in cancer patients

被引：13

作者：

Mercadante, S

Avola, G

Maddaloni, S

Salamone, G

Aragona, F

Rodolico, V

机构：

[1] BUCHERI LA FERLA FATEBENEFRATELLI,DEPT ANESTHESIA & INTENS CARE,PALERMO,ITALY

[2] BUCHERI LA FERLA FATEBENEFRATELLI,DEPT SURG,PALERMO,ITALY

[3] UNIV PALERMO,INST PATHOL ANAT,PALERMO,ITALY

来源：

SUPPORTIVE CARE IN CANCER | 1996年 / 4卷 / 05期

关键词：

D O I：

10.1007/BF01788848

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：393 / 394

页数：2

共 5 条

[1] DOES VASOACTIVE INTESTINAL POLYPEPTIDE MEDIATE THE PATHO-PHYSIOLOGY OF BOWEL OBSTRUCTION [J].

BASSON, MD ;

FIELDING, LP ;

BILCHIK, AJ ;

ZUCKER, KA ;

BALLANTYNE, GH ;

SUSSMAN, J ;

ADRIAN, TE ;

MODLIN, IM .

AMERICAN JOURNAL OF SURGERY, 1989, 157 (01) :109-115

[2] CONTROL OF EMESIS IN BOWEL OBSTRUCTION IN TERMINALLY ILL PATIENTS [J].

KHOO, D ;

RILEY, J ;

WAXMAN, J .

LANCET, 1992, 339 (8789) :375-376

[3] OCTREOTIDE IN THE MANAGEMENT OF INOPERABLE GASTROINTESTINAL OBSTRUCTION IN TERMINAL CANCER-PATIENTS [J].

MERCADANTE, S ;

MADDALONI, S .

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1992, 7 (08) :496-498

[4]

MERCADANTE S, 1996, IN PRESS SUPPORTIVE

[5] CRITICAL OPERATIVE MANAGEMENT OF SMALL BOWEL OBSTRUCTION [J].

STEWARDSON, RH ;

BOMBECK, CT ;

NYHUS, LM .

ANNALS OF SURGERY, 1978, 187 (02) :189-193

← 1 →